Enveric Biosciences Inc ENVB Q4 2024 Earnings Massive EPS Miss Highlights Ongoing Cash Burn and No Revenue RTX Q1 2026 Earnings Solid EPS Beat Driven by Strong Commercial and Defense Demand DSGN Q1 2026 Earnings NarrowerThanExpected Loss as Cost Discipline Continues Ernexa Therapeutics Q3 2023 Earnings Losses Deepen as Stock Declines No Revenue Reported BEEM Q1 2026 Earnings EPS Misses Estimates as Beam Global Reports WiderThanExpected Loss MDT Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction